Brain Perfusion & Oxygenation in Parkinson's Disease With NOH
Trial
Phase 4
Completed
Sept. 5, 2022
Gut Health and Probiotics in Parkinson's (SymPD)
Trial
N/A
Unknown
Sept. 1, 2022
Parkinsonian Patients Treated With Apomorphine Pump: Observatory of Skin Lesions
Trial
N/A
Unknown
Aug. 31, 2022
Whey Protein Supplementation in Patients With Parkinson's Disease
Trial
N/A
Completed
Aug. 30, 2022
Effect of Aerobic Training on Oxidative Stress Markers in Patients With Parkinson's Disease
Trial
N/A
Unknown
Aug. 24, 2022
Evaluation of a Semiconductor Camera for the DaTSCANā¢ Exam
Trial
N/A
Completed
Aug. 23, 2022
Digital GaitCare - Therapy Monitoring in the Home Environment of Patients With Parkinson
Trial
N/A
Completed
Aug. 23, 2022
Investigating Cerebellar Inhibition and Its Clinical Significance in Parkinsonian Tremor and Intention Tremor
Trial
N/A
Unknown
Aug. 22, 2022
Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients
Trial
Early Phase 1
Completed
Aug. 18, 2022
Mapping the Target for the MRgFUS Treatment of Tremor
Trial
N/A
Completed
Aug. 14, 2022
Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System
Trial
N/A
Recruiting
Aug. 8, 2022
Intranasal Human FGF-1 for Subjects With Parkinson's Disease
Trial
Phase 1
Unknown
Aug. 8, 2022
NR-SAFE: Safety of High-dose Nicotinamide Riboside (NR) in Parkinson's Disease
Trial
N/A
Completed
Aug. 8, 2022
Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients
Trial
Phase 2
Unknown
Aug. 7, 2022
Telehealth Psychotherapy for Depression in Parkinson's Disease
Trial
N/A
Completed
Aug. 7, 2022
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients
Trial
Phase 2
Completed
Aug. 7, 2022
Group Versus Individuals Telehealth Exercise Programs for People With Parkinson Disease
Trial
N/A
Completed
Aug. 2, 2022
A Study to Analyze Symptoms Prevalent in Early PD (Dysphonia, Tremor)
Trial
N/A
Unknown
Aug. 2, 2022